Articles dans des revues avec comité de lecture (260)

  1. 166. Pryce, G., Ahmed, Z., Hankey, D. J. R., Jackson, S. J., Croxford, J. L., Pocock, J. M., Ledent, C., Petzold, A., Thompson, A. J., Giovannoni, G., Cuzner, M. L., & Baker, D. (2003). Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain, 126(Pt 10), 2191-2202. doi:10.1093/brain/awg224
  2. 167. Köfalvi, A., Vizi, E. S., Ledent, C., & Sperlágh, B. (2003). Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action. European journal of neuroscience, 18(7), 1973-1978. doi:10.1046/j.1460-9568.2003.02897.x
  3. 168. Köfalvi, A., Vizi, E. S., Ledent, C., & Sperlágh, B. (2003). Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action. European journal of neuroscience, 18(7), 1973-1978. doi:10.1046/j.1460-9568.2003.02897.x
  4. 169. Wang, J. H., Short, J. L., Ledent, C., Lawrence, A. J., & van den Buuse, M. (2003). Reduced startle habituation and prepulse inhibition in mice lacking the adenosine A2A receptor. Behavioural brain research, 143(2), 201-207.
  5. 170. Blum, D., Galas, M.-C., Pintor, A., Brouillet, E., Ledent, C., Muller, C. E., Bantubungi, K., Galluzzo, M., Gall, D., Cuvelier, L., Rolland, A.-S., Popoli, P., & Schiffmann, S. N. (2003). A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists. The Journal of neuroscience, 23(12), 5361-5369.
  6. 171. Gérard, A.-C., Denef, J. F., Many, M.-C., Gathy, P., de Burbure, C., Van Den Hove, M.-F., Coppee, F., Ledent, C., & Colin, I. M. (2003). Relationships between cell division, expression of growth factors and microcirculation in the thyroids of Tg-A2aR transgenic mice and patients with Graves' disease. Journal of Endocrinology, 177(2), 269-277. doi:10.1677/joe.0.1770269
  7. 172. Talukder, M. A. H., Morrison, R. R., Ledent, C., & Mustafa, S. J. (2003). Endogenous adenosine increases coronary flow by activation of both A2A and A2B receptors in mice. Journal of cardiovascular pharmacology, 41(4), 562-570.
  8. 173. Derkinderen, P., Valjent, E., Toutant, M., Corvol, J.-C., Enslen, H., Ledent, C., Trzaskos, J., Caboche, J., & Girault, J. A. (2003). Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. The Journal of neuroscience, 23(6), 2371-2382. doi:10.1523/jneurosci.23-06-02371.2003
  9. 174. Adén, U., Halldner, L., Lagercrantz, H., Dalmau, I., Ledent, C., & Fredholm, B. B. (2003). Aggravated brain damage after hypoxic ischemia in immature adenosine A2A knockout mice. Stroke, 34(3), 739-744. doi:10.1161/01.STR.0000060204.67672.8B
  10. 175. Ates, M., Hamza, M., Seidel, K., Kotalla, C. E., Ledent, C., & Gühring, H. (2003). Intrathecally applied flurbiprofen produces an endocannabinoid-dependent antinociception in the rat formalin test. European journal of neuroscience, 17(3), 597-604. doi:10.1046/j.1460-9568.2003.02470.x
  11. 176. Berrendero, F., Castañé, A., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2003). Increase of morphine withdrawal in mice lacking A2a receptors and no changes in CB1/A2a double knockout mice. European journal of neuroscience, 17(2), 315-324. doi:10.1046/j.1460-9568.2003.02439.x
  12. 177. Soria, G., Castane, A., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2003). The role of A2a adenosine receptors in cannabinoid dependence. Behavioural pharmacology, 14, 59.

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Suivant >>